DE60335374D1 - Canine respiratory coronavirus (crcv) spike protein, polymerase und hemaggllutinin/esterase - Google Patents
Canine respiratory coronavirus (crcv) spike protein, polymerase und hemaggllutinin/esteraseInfo
- Publication number
- DE60335374D1 DE60335374D1 DE60335374T DE60335374T DE60335374D1 DE 60335374 D1 DE60335374 D1 DE 60335374D1 DE 60335374 T DE60335374 T DE 60335374T DE 60335374 T DE60335374 T DE 60335374T DE 60335374 D1 DE60335374 D1 DE 60335374D1
- Authority
- DE
- Germany
- Prior art keywords
- crcv
- coronavirus
- esterase
- canine
- hemaggllutinin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 241001594994 Canine respiratory coronavirus Species 0.000 title abstract 4
- 108090000371 Esterases Proteins 0.000 title abstract 2
- 229940096437 Protein S Drugs 0.000 title 1
- 101710198474 Spike protein Proteins 0.000 title 1
- 241000711443 Bovine coronavirus Species 0.000 abstract 1
- 241000711506 Canine coronavirus Species 0.000 abstract 1
- 241000282465 Canis Species 0.000 abstract 1
- 241000282472 Canis lupus familiaris Species 0.000 abstract 1
- 101710154606 Hemagglutinin Proteins 0.000 abstract 1
- 241001428935 Human coronavirus OC43 Species 0.000 abstract 1
- 101710093908 Outer capsid protein VP4 Proteins 0.000 abstract 1
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 abstract 1
- 101710176177 Protein A56 Proteins 0.000 abstract 1
- 239000002299 complementary DNA Substances 0.000 abstract 1
- 239000000185 hemagglutinin Substances 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002458 infectious effect Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 210000002345 respiratory system Anatomy 0.000 abstract 1
- 208000023504 respiratory system disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0217434.0A GB0217434D0 (en) | 2002-07-27 | 2002-07-27 | Biological material |
| PCT/GB2003/002832 WO2004011651A1 (en) | 2002-07-27 | 2003-07-01 | Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60335374D1 true DE60335374D1 (en) | 2011-01-27 |
Family
ID=9941223
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60335374T Expired - Lifetime DE60335374D1 (en) | 2002-07-27 | 2003-07-01 | Canine respiratory coronavirus (crcv) spike protein, polymerase und hemaggllutinin/esterase |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US7776340B2 (de) |
| EP (2) | EP2182066A3 (de) |
| JP (1) | JP4644486B2 (de) |
| AT (1) | ATE491793T1 (de) |
| AU (1) | AU2003244822B2 (de) |
| CA (2) | CA2727782C (de) |
| CY (1) | CY1111655T1 (de) |
| DE (1) | DE60335374D1 (de) |
| DK (1) | DK1525313T3 (de) |
| ES (1) | ES2384445T3 (de) |
| GB (1) | GB0217434D0 (de) |
| MX (1) | MXPA05001098A (de) |
| NO (1) | NO20050979L (de) |
| NZ (2) | NZ556442A (de) |
| PT (1) | PT1525313E (de) |
| SI (1) | SI1525313T1 (de) |
| WO (1) | WO2004011651A1 (de) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004060278A2 (en) | 2002-12-06 | 2004-07-22 | Isis Pharmaceuticals, Inc. | Methods for rapid identification of pathogens in humans and animals |
| US7226739B2 (en) | 2001-03-02 | 2007-06-05 | Isis Pharmaceuticals, Inc | Methods for rapid detection and identification of bioagents in epidemiological and forensic investigations |
| US20030027135A1 (en) | 2001-03-02 | 2003-02-06 | Ecker David J. | Method for rapid detection and identification of bioagents |
| US7666588B2 (en) | 2001-03-02 | 2010-02-23 | Ibis Biosciences, Inc. | Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy |
| US20040121335A1 (en) | 2002-12-06 | 2004-06-24 | Ecker David J. | Methods for rapid detection and identification of bioagents associated with host versus graft and graft versus host rejections |
| US7217510B2 (en) | 2001-06-26 | 2007-05-15 | Isis Pharmaceuticals, Inc. | Methods for providing bacterial bioagent characterizing information |
| US8073627B2 (en) | 2001-06-26 | 2011-12-06 | Ibis Biosciences, Inc. | System for indentification of pathogens |
| US8057993B2 (en) | 2003-04-26 | 2011-11-15 | Ibis Biosciences, Inc. | Methods for identification of coronaviruses |
| US8158354B2 (en) | 2003-05-13 | 2012-04-17 | Ibis Biosciences, Inc. | Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture |
| US7964343B2 (en) | 2003-05-13 | 2011-06-21 | Ibis Biosciences, Inc. | Method for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture |
| US9023366B2 (en) | 2003-07-01 | 2015-05-05 | The Royal Veterinary College | Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD) |
| GB0315323D0 (en) * | 2003-07-01 | 2003-08-06 | Royal Veterinary College | Vaccine composition |
| US8546082B2 (en) | 2003-09-11 | 2013-10-01 | Ibis Biosciences, Inc. | Methods for identification of sepsis-causing bacteria |
| US20120122096A1 (en) | 2003-09-11 | 2012-05-17 | Rangarajan Sampath | Compositions for use in identification of bacteria |
| US8097416B2 (en) | 2003-09-11 | 2012-01-17 | Ibis Biosciences, Inc. | Methods for identification of sepsis-causing bacteria |
| US8163895B2 (en) | 2003-12-05 | 2012-04-24 | Ibis Biosciences, Inc. | Compositions for use in identification of orthopoxviruses |
| US7666592B2 (en) | 2004-02-18 | 2010-02-23 | Ibis Biosciences, Inc. | Methods for concurrent identification and quantification of an unknown bioagent |
| WO2006076007A2 (en) * | 2004-04-22 | 2006-07-20 | Vanderbilt University | Methods of detecting coronavirus infections |
| EP2458619B1 (de) | 2004-05-24 | 2017-08-02 | Ibis Biosciences, Inc. | Massenspektrometrie mit selektivem Ionfilter durch digitale Schwelle |
| US20050266411A1 (en) | 2004-05-25 | 2005-12-01 | Hofstadler Steven A | Methods for rapid forensic analysis of mitochondrial DNA |
| US7811753B2 (en) | 2004-07-14 | 2010-10-12 | Ibis Biosciences, Inc. | Methods for repairing degraded DNA |
| US8084207B2 (en) | 2005-03-03 | 2011-12-27 | Ibis Bioscience, Inc. | Compositions for use in identification of papillomavirus |
| WO2006094238A2 (en) | 2005-03-03 | 2006-09-08 | Isis Pharmaceuticals, Inc. | Compositions for use in identification of adventitious viruses |
| WO2007014045A2 (en) | 2005-07-21 | 2007-02-01 | Isis Pharmaceuticals, Inc. | Methods for rapid identification and quantitation of nucleic acid variants |
| CN101309701A (zh) | 2005-10-07 | 2008-11-19 | 辉瑞产品公司 | 治疗犬流感的疫苗和方法 |
| EP1780216B1 (de) * | 2005-10-26 | 2010-12-29 | Canio Buonavoglia | Pantropisches Hundecoronavirus |
| US7682619B2 (en) | 2006-04-06 | 2010-03-23 | Cornell Research Foundation, Inc. | Canine influenza virus |
| WO2008143627A2 (en) | 2006-09-14 | 2008-11-27 | Ibis Biosciences, Inc. | Targeted whole genome amplification method for identification of pathogens |
| US8871471B2 (en) | 2007-02-23 | 2014-10-28 | Ibis Biosciences, Inc. | Methods for rapid forensic DNA analysis |
| WO2008151023A2 (en) | 2007-06-01 | 2008-12-11 | Ibis Biosciences, Inc. | Methods and compositions for multiple displacement amplification of nucleic acids |
| US8550694B2 (en) | 2008-09-16 | 2013-10-08 | Ibis Biosciences, Inc. | Mixing cartridges, mixing stations, and related kits, systems, and methods |
| US8148163B2 (en) | 2008-09-16 | 2012-04-03 | Ibis Biosciences, Inc. | Sample processing units, systems, and related methods |
| EP2344893B1 (de) | 2008-09-16 | 2014-10-15 | Ibis Biosciences, Inc. | Mikroplatten-handhabungssysteme und verfahren |
| EP2396803A4 (de) | 2009-02-12 | 2016-10-26 | Ibis Biosciences Inc | Ionisationssondenanordnungen |
| US9194877B2 (en) | 2009-07-17 | 2015-11-24 | Ibis Biosciences, Inc. | Systems for bioagent indentification |
| WO2011008971A1 (en) | 2009-07-17 | 2011-01-20 | Ibis Biosciences, Inc. | Lift and mount apparatus |
| US9890408B2 (en) | 2009-10-15 | 2018-02-13 | Ibis Biosciences, Inc. | Multiple displacement amplification |
| RU2553222C2 (ru) * | 2011-02-04 | 2015-06-10 | ЗОИТИС ЭлЭлСи | Композиции для лечения и предупреждения комплекса респираторных заболеваний собак |
| ES2869175T3 (es) * | 2011-02-04 | 2021-10-25 | Zoetis Services Llc | Composiciones inmunógenas de Bordetella bronchiseptica |
| ITMI20111182A1 (it) * | 2011-06-28 | 2012-12-29 | Canio Buonavoglia | Vaccino per coronavirus canino |
| ES2748205T3 (es) * | 2012-05-31 | 2020-03-13 | Zoetis Services Llc | Vacunación con coronavirus respiratorio canino para protección contra infecciones por B. Bronchiseptica |
| CN105803112A (zh) * | 2016-03-28 | 2016-07-27 | 中国人民解放军成都军区疾病预防控制中心 | 用于检测犬细小病毒的引物、探针和试剂盒及检测方法 |
| CN108318685A (zh) * | 2018-05-04 | 2018-07-24 | 广州敏捷生物技术有限公司 | 用于检测犬冠状病毒抗原的免疫荧光层析检测卡与制备方法 |
| CN111254155A (zh) * | 2020-01-25 | 2020-06-09 | 王跃驹 | 一种植物作为宿主表达病毒疫苗的方法 |
| CN111592602B (zh) * | 2020-02-10 | 2021-03-02 | 中国科学院微生物研究所 | 一种β冠状病毒抗原、其制备方法和应用 |
| CN112094953B (zh) * | 2020-10-30 | 2022-11-11 | 内蒙古农业大学 | 用于同时检测牛病毒性腹泻病毒、牛轮状病毒和牛冠状病毒的试剂盒及引物和探针 |
| US11175293B1 (en) | 2021-01-04 | 2021-11-16 | University Of Utah Research Foundation | Rapid assay for detection of SARS-CoV-2 antibodies |
| CA3106787A1 (en) * | 2021-01-22 | 2022-07-22 | Amphotericin B Technologies Inc. | Use of amphotericin b in the treatment of coronavirus diseases |
| CN116854784B (zh) * | 2023-09-05 | 2023-11-17 | 北京纳百生物科技有限公司 | 犬冠状病毒n蛋白抗原截短体及其应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4567043A (en) * | 1983-06-15 | 1986-01-28 | American Home Products Corporation (Del.) | Canine corona virus vaccine |
| US5672350A (en) * | 1989-08-22 | 1997-09-30 | Veterinary Infectious Disease Organization | Recombinant bovine coronavirus E2 and E3 polypeptides and vaccines |
| US6057436A (en) * | 1990-11-14 | 2000-05-02 | Pfizer Inc. | Canine coronavirus S gene and uses therefor |
| US6372224B1 (en) * | 1990-11-14 | 2002-04-16 | Pfizer Inc. | Canine coronavirus S gene and uses therefor |
| NZ240558A (en) * | 1990-11-14 | 1994-11-25 | Smithkline Beecham Corp | Recombinant feline coronavirus s proteins useful in diagnosis and vaccination against feline peritonitis virus disease |
| EP0510773B1 (de) * | 1991-04-25 | 2003-12-17 | Akzo Nobel N.V. | Subeinheits-Impfstoff gegen Hundecoronavirus |
| EP0640098B1 (de) | 1992-05-08 | 2002-10-09 | Pfizer Inc. | Hundecoronavirus s gen und verwendung davon |
| US5750112A (en) * | 1993-02-26 | 1998-05-12 | Solvay Animal Health, Inc. | Canine coronavirus vaccine from feline enteric coronavirus |
| DE69633233T2 (de) * | 1995-06-12 | 2005-08-11 | Kansas State University Research Foundation, Manhattan | Multivalenter impstoff gegen bovines coronavirus und methode zur behandlung einer infektion mit bovinem coronavirus |
| WO1998016643A1 (en) | 1996-10-11 | 1998-04-23 | Human Genome Sciences, Inc. | Brain-associated inhibitor of tissue-type plasminogen activator |
| AU1408499A (en) | 1997-11-14 | 1999-06-07 | Thomas P. Brown | Compositions and methods to prevent turkey enteritis |
| US6974577B2 (en) * | 2001-02-04 | 2005-12-13 | Novartris Ag | Inactivated bovine scours vaccines, processes and method of preventing bovine scours |
-
2002
- 2002-07-27 GB GBGB0217434.0A patent/GB0217434D0/en not_active Ceased
-
2003
- 2003-07-01 MX MXPA05001098A patent/MXPA05001098A/es active IP Right Grant
- 2003-07-01 PT PT03738299T patent/PT1525313E/pt unknown
- 2003-07-01 DE DE60335374T patent/DE60335374D1/de not_active Expired - Lifetime
- 2003-07-01 AT AT03738299T patent/ATE491793T1/de active
- 2003-07-01 ES ES03738299T patent/ES2384445T3/es not_active Expired - Lifetime
- 2003-07-01 NZ NZ556442A patent/NZ556442A/en not_active IP Right Cessation
- 2003-07-01 NZ NZ537778A patent/NZ537778A/en not_active IP Right Cessation
- 2003-07-01 CA CA2727782A patent/CA2727782C/en not_active Expired - Fee Related
- 2003-07-01 EP EP09075521A patent/EP2182066A3/de not_active Withdrawn
- 2003-07-01 SI SI200331946T patent/SI1525313T1/sl unknown
- 2003-07-01 US US10/522,513 patent/US7776340B2/en not_active Expired - Fee Related
- 2003-07-01 WO PCT/GB2003/002832 patent/WO2004011651A1/en active Application Filing
- 2003-07-01 AU AU2003244822A patent/AU2003244822B2/en not_active Ceased
- 2003-07-01 DK DK03738299.1T patent/DK1525313T3/da active
- 2003-07-01 JP JP2004523905A patent/JP4644486B2/ja not_active Expired - Fee Related
- 2003-07-01 CA CA2492333A patent/CA2492333C/en not_active Expired - Fee Related
- 2003-07-01 EP EP03738299A patent/EP1525313B1/de not_active Expired - Lifetime
-
2005
- 2005-02-23 NO NO20050979A patent/NO20050979L/no not_active Application Discontinuation
-
2008
- 2008-09-26 US US12/239,527 patent/US7981427B2/en not_active Expired - Fee Related
-
2011
- 2011-02-14 CY CY20111100173T patent/CY1111655T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY1111655T1 (el) | 2015-10-07 |
| CA2492333C (en) | 2013-08-20 |
| US7776340B2 (en) | 2010-08-17 |
| AU2003244822A1 (en) | 2004-02-16 |
| CA2492333A1 (en) | 2004-02-05 |
| NO20050979D0 (no) | 2005-02-23 |
| EP2182066A3 (de) | 2010-08-11 |
| DK1525313T3 (da) | 2011-03-14 |
| ATE491793T1 (de) | 2011-01-15 |
| JP4644486B2 (ja) | 2011-03-02 |
| EP1525313A1 (de) | 2005-04-27 |
| EP2182066A2 (de) | 2010-05-05 |
| US7981427B2 (en) | 2011-07-19 |
| CA2727782A1 (en) | 2004-02-05 |
| NO20050979L (no) | 2005-04-25 |
| NZ537778A (en) | 2008-04-30 |
| PT1525313E (pt) | 2011-03-14 |
| EP1525313B1 (de) | 2010-12-15 |
| AU2003244822B2 (en) | 2009-01-29 |
| ES2384445T3 (es) | 2012-07-05 |
| US20090081780A1 (en) | 2009-03-26 |
| JP2005533513A (ja) | 2005-11-10 |
| CA2727782C (en) | 2016-10-11 |
| MXPA05001098A (es) | 2005-09-08 |
| NZ556442A (en) | 2009-03-31 |
| GB0217434D0 (en) | 2002-09-04 |
| WO2004011651A1 (en) | 2004-02-05 |
| US20070248616A1 (en) | 2007-10-25 |
| SI1525313T1 (sl) | 2011-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60335374D1 (en) | Canine respiratory coronavirus (crcv) spike protein, polymerase und hemaggllutinin/esterase | |
| DE122011100037I1 (de) | Rekombinante influenzaviren zur vakzinherstellung und gentherapie. | |
| ATE440571T1 (de) | Künstliches gelenkelement sowie ein damit ausgestattetes greifwerkzeug | |
| ATE452665T1 (de) | Spül- und absaugsystem | |
| EP1419746A3 (de) | Zahnimplantatsystem | |
| SE0100127D0 (sv) | Implantat för rekonstruktion av leder | |
| EP2308413A3 (de) | Modifiziertes Fixierteil für Zahnimplantate | |
| HK1083454A1 (en) | Recombinant vaccine viruses expressing il-15 and methods of using the same 15(il-15) | |
| EA200401507A1 (ru) | Межгенные области, используемые в качестве инсерционных сайтов в геноме модифицированного вируса коровьей оспы анкара (mva) | |
| BR0313321A (pt) | Escova de dentes | |
| IL174983A0 (en) | Immunogenic composition and method of developing a vaccine based on portions of the hiv matrix protein | |
| DK1928345T3 (da) | Tandimplantat | |
| DE60327164D1 (de) | Dentales implantatsystem | |
| CY1108775T1 (el) | Παρασκευη πεπτιδιων σωματοστατινης | |
| BR0315856A (pt) | Trilho de brinquedo e método de montagem e desmontagem do mesmo | |
| AU2003289631A1 (en) | A recombinant adenovirus relating gene vaccine used to therapy and prevent alzheimers disease, and use thereof | |
| ATE380517T1 (de) | Verbessertes enossales dentalimplantat | |
| EP1389043A4 (de) | Impfstoff gegen das maul- und -klauensäure-virus | |
| DE69818913D1 (de) | Rekombinanter Birnavirusimpfstoff | |
| ATE511829T1 (de) | Fsh-glykosylierungsmutante | |
| ATE283670T1 (de) | Knochen-befestigungssystem | |
| CN103565615B (zh) | 牙床按摩器 | |
| DE60332635D1 (de) | Beruhigende vogel-pheromone zur verminderung von stress, angst und aggressivität | |
| FR2892916B1 (fr) | Clou centromedullaire d'osteosynthese | |
| CN103565614B (zh) | 骨突消除按摩器 |